GlaxoSmithKline Pharmaceuticals reply to clarification sought by the exchange

09 Jun 2015 Evaluate

The Exchange had sought clarification from GlaxoSmithKline Pharmaceuticals with respect to news appearing in Business Standard dated June 06, 2015 titled ‘CCI slaps Rs 64 cr fine on GlaxoSmithKline, Sanofi.’ GlaxoSmithKline Pharmaceuticals response is enclosed.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2504.35 31.10 (1.26%)
07-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.